What is a Discussion Group? Problems Using Discussion Group? Changing E-mail Address?

Pharmacovigilance Discussion Group

PharmacoVigilance Review

The Pharmacovigilance (PV) Discussion Group is designed to provide a vehicle for the free exchange of information relating to pharmacovigilance.

The PV Discussion Group is sponsored by PharmacoVigilance Review, a quarterly publication researched and edited by an expert team experienced in all aspects of the safe use of medicines and medical devices.

Unlike any other information source, PharmacoVigilance Review is dedicated to helping you understand and keep up with the often complex and jargon-ridden regulations which are being introduced all the time from Brussels, the FDA and other agencies.

Thus, PharmacoVigilance Review will not simply list new regulations! Each item will come with analysis and comment on its effect on you and your company. Each issue will also contain reviews on specialist topics relating to drug safety and pharmacovigilance and provide highlights of relevant conferences.

The PV Discussion Group is being moderated by Professor Tony D'Emanuele, founder of PharmWeb and Head of the School of Pharmacy and Pharmaceutical Sciences, University of Central Lancashire.

If you would like to read messages sent to the group you can either view the archive, or alternatively, directly receive e-mail messages by joining the group.

Mail Archives

Select the archive you would like to view

Sending a Message to the Discussion Group

You can contribute by sending an e-mail message to pharmacovigilance@www2.pharmweb.net

Please remember to write your name and e-mail address at the bottom of your message

Alternatively, use the form below:

E-mail address:




Please complete all sections and check that your e-mail address is correct.

Joining/Leaving the Discussion Group

If you would like to join or leave this discussion group then please submit the form below. If you join the group then an e-mail message will be sent to you confirming your request. Once you receive this e-mail, please respond within 7 days to confirm that you wish to join the discussion group. Please note that a reply will only be sent to a valid e-mail address (if you do not receive a message your e-mail address may not have been recognised).

A help file can also be obtained using this form. This will explain how to use this service using simple e-mail commands rather than a web interface.

E-mail address:
Your name :

PharmWeb? - Copyright?1994-2011. All rights reserved